|
|
|
|
LEADER |
00000cam a22000004a 4500 |
001 |
ELB171749 |
003 |
FINmELB |
005 |
20220615121057.0 |
006 |
m o u |
007 |
cr cn||||||||| |
008 |
050808s2006 paua b 001 0 eng |
020 |
|
|
|z 9780781756280
|
035 |
|
|
|a (OCoLC)1077998233
|
040 |
|
|
|a FINmELB
|c FINmELB
|d FINmELB
|
050 |
0 |
0 |
|a RC271.C5
|b C32219 2006
|
060 |
0 |
0 |
|a 2005 N-986
|
060 |
1 |
0 |
|a QZ 267
|b C21515 2006
|
082 |
0 |
0 |
|a 616.99/4061
|2 22
|
096 |
|
|
|a QZ 267
|b C215 2006
|
096 |
|
|
|a QZ267 .C21515 2006
|
245 |
0 |
0 |
|a Cancer chemotherapy and biotherapy :
|b principles and practice /
|c editors Bruce A. Chabner, Dan L. Longo.
|
250 |
|
|
|a 4th ed.
|
260 |
|
|
|a Philadelphia :
|b Lippincott Williams & Wilkins,
|c c2006.
|
300 |
|
|
|a 1 online resource (xv, 879 p.) :
|b ill. (some col.)
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Delivering anticancer drugs to brain tumors / Maciej M. Mrugala, Tracy T. Batchelor, Jeffrey G. Supko -- Food and drug administration role in oncology product development / Thomas G. Roberts Jr. -- Central venous catheters: care and complications / Rachel P. Rosovsky, David J. Kuter -- Pharmacogenetics / Jeanne Fourie, Robert B. Diasio -- New targets for anticancer therapeutics / A. Dimitrios Colevas ... [et al.] -- Bisphosphonates / Matthew R. Smith -- Thalidomide and its analogs for the treatment of hematologic malignancies, including multiple myeloma, and solid tumors / Paul Richardson ... [et al.] -- Inhibitors of tumor angiogenesis / Anaadriana Zakarija, William J. Gradishar -- Proteasome inhibitors / Owen A. O'Connor -- Molecular targeted drugs and growth factor receptor inhibitors / Jeffrey W. Clark -- Antibody therapies of cancer / David A. Scheinberg ... [et al.] -- Interferons / Daniel J. Lindner ... [et al.] -- Adoptive cellular therapies / Carl H. June -- Cancer vaccines / Glenn Dranoff -- Hematopoietic growth factors / William P. Petros -- Interleukins / Gheath Alatrash ... [et al.] -- Harmonal therapy for breast cancer / Peter F. Lebowitz, Sandra M. Swain.
|5 FOFT
|
505 |
0 |
|
|a Clinical strategies for cancer treatment: the role of drugs / Bruce Chabner -- Preclinical aspects of cancer drug discovery and development / Paula Krosky ... [et al.] -- Pharmacokinetics / Jerry Collins, Jeffrey G. Supko -- Infertility after cancer chemotherapy / Angela Bradbury, Richard L. Schilsky -- Carcinogenesis of anticancer drugs / Laawrence S. Blaszkowsky, Charles Erlichman -- Antifolates / Brian P. Monahan, Carmen J. Allegra -- 5-Fluoropyrimidine / Jean L. Grem -- Cytidine analogues / David P. Ryan, Rocio Garcia-Carbonero, Bruce A. Chabner -- Purine antimetabolites / Kenneth R. Hande -- Hydroxyurea / Luis Paz-Ares, Ross C. Donehower, Bruce A. Chabner -- Antimicrotubule agents / Eric K. Rowinsky -- Clinical and high-dose alkylating agents / Kenneth D. Tew, O. Michael Colvin, Roy B. Jones -- Nonclassic agents / Henry S. Friedman, Steven D. Averbuch, Joanne Kurtzberg -- Cisplatin, Carboplatin, and oxaliplatin / Eddie Reed -- Bleomycin / John s. Lazo, Bruce A. Chabner -- Antitumor antibiotics / Edwin W. Willems, Kees Nooter, Jaap Verweij -- Topoisomerase I-targeting drugs / Alex Sparreboom, William C. Zamboni -- Anthracyclines and anthracenediones / James H. Doroshow -- Topoisomerase II inhibitors: the epipodophyllotoxins, acridines, and ellipticines / Yves Pommier, François Goldwasser -- Asparaginase / Bruce A. Chabner, Alison M. Friedmann --
|5 FOFT
|
505 |
0 |
|
|a Clinical strategies / Bruce Chabner -- Preclinical aspects of cancer drug discovery / Ed Sausville ... [et al.] -- Pharmacokinetics / Jerry Collins -- Infertility / Angela Bradbury, Richard Schilsky -- Carcinogenesis / Larry Blaszkowsky -- Antifolates / Carmen Allegra, Brian Monahan -- 5 fluoropyrimidine / Jean Grem -- Cytidine analogues / David Ryan -- Purine analogues / Kenneth Hande -- Hydroxyurea / Bruce Chabner -- Antimicrotuble agents / Eric Rowinsky -- Alkylating agents/clinical & high dose / Roy Jones, Ken Tew -- Nonclassical agents / Henry Friedman -- Platinum analogues / Ed Reed -- Bleomycin / Bruce Chabner -- Antibiotics / Kees Nooter, Jaap Verweij, Edwin Willems -- Topo I: inhibitors / Alex Sparreboom, William Zamboni -- Topo II: anthracyclines / Jim Doroshow -- Topo II: epipodophylotoxins / Yves Pommier, Francios Goldwasser -- L-asparaginase / Bruce Chabner -- Pharmacology of CNS agents / Jeff Supko -- FDA approval / Thomas Roberts -- Catheter and complications / David Kuter, Rachel Rosovsky -- Pharmacogenetics / Robert Diasio, Jeanne Fourie -- New agents / Louise Grochow -- Bisphosphonates / Matthew Smith -- Thalidomide / Paul Richardson -- Inhibitors of tumor angiogenesis / William Gradishar, Anaadriana Zakarija -- Proteosome inhibitors / Owen O'Connor -- Molecular targeted drugs-growth factor receptor inhibitors / Jeff Clark -- Monoclonal antibody therapies / David Scheinberg -- Interferon / Danield Linder, Earnest Borden -- Adoptive therapies / Carl June -- Vaccines / Glenn Dranoff -- Hematopoietic growth factors / William Petros -- Interleukins / Gheath Alatrash ... [et al.] -- Hormonal therapy for breast cancer and prostate / Peter Lebowitz, Sandra Swain, Steven Balk.
|5 FU
|
530 |
|
|
|a Also issued online.
|5 FOFT
|
588 |
|
|
|a Description based on metadata supplied by the publisher and other sources.
|
590 |
|
|
|a Electronic reproduction. Santa Fe, Arg.: elibro, 2022. Available via World Wide Web. Access may be limited to eLibro affiliated libraries.
|
650 |
|
0 |
|a Biological response modifiers.
|
650 |
|
0 |
|a Antineoplastic agents.
|
650 |
|
0 |
|a Cancer
|x Immunotherapy.
|
650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
650 |
1 |
2 |
|a Neoplasms
|x drug therapy.
|
650 |
2 |
2 |
|a Biological Products
|x therapeutic use.
|
650 |
2 |
2 |
|a Antineoplastic Agents
|x therapeutic use.
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Longo, Dan L.
|q (Dan Louis),
|d 1949-
|
700 |
1 |
|
|a Chabner, Bruce.
|
797 |
2 |
|
|a elibro, Corp.
|
856 |
4 |
0 |
|u https://elibro.uam.elogim.com/ereader/bidiuam/171749
|z Texto completo
|